ANAURAN

ANAURAN EAR DROPS, SOLUTION 1 BOTTLE 25 ML

ANAURAN EAR DROPS, SOLUTION 1 BOTTLE 25 ML

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Name
Anauran ear drops, solution
Polymyxin B sulfate, Neomycin sulfate, Lidocaine hydrochloride



What is it and what is it used for?
Anauran contains the active substances polymyxin B sulfate, neomycin sulfate and lidocaine hydrochloride.

The medicine consists of a combination of antibiotics and a local anesthetic.

Anauran is indicated in adults and children for the treatment of acute and chronic ear infections.

Contact your doctor if you do not feel better or if you feel worse after three days.


What you need to know before taking the medicine
Do not use Anauran:
- if you are allergic (hypersensitive) to polymyxin B sulphate, neomycin sulphate and lidocaine hydrochloride or any of the other ingredients of this medicine (listed in section 6)
- if you have a perforated eardrum, due to the risk of damage to your ear


Warnings and precautions
Talk to your doctor or pharmacist before using Anauran.

Use of topical products such as Anauran, especially if prolonged, may cause sensitization. If this occurs, discontinue use and consult your doctor to initiate appropriate therapy.
In the presence of deep or resistant infections, it is advisable to integrate the local dressing with appropriate general antibiotic treatments.
As with other antibiotic medicines, prolonged treatment can lead to further infections (called “superinfections”) from germs that are resistant to the same antibiotic therapies.
Neomycin, one of the active ingredients in this medicine, can cause permanent hearing loss. The risk of ear damage is greater with prolonged use, so it is recommended that treatment be limited to 10 consecutive days.
If you have had allergic reactions or resistance to other antibiotics similar to neomycin (aminoglycosides), these may also occur with the use of Anauran.


Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been reported following the administration of Anauran:

Frequency not known (frequency cannot be estimated from the available data)
• Allergic skin reaction (allergic dermatitis), itching
• Irritation at the application site
• Damage to the ear (ototoxicity)

Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.

ANAURAN

ANAURAN EAR DROPS, SOLUTION 1 BOTTLE 25 ML

ANAURAN EAR DROPS, SOLUTION 1 BOTTLE 25 ML

MINSAN code: 014302032
Previous price: €11,40
Regular price €11,40
Regular price €0,00 Sale price €11,40
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.